JESSICA DIFABIO: Open Payments
NPI 1508315730 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$49 in 2 payments from 2 companies in 2025. Trend: 2023 $97 · 2024 $77 · 2025 $49
Food & beverage: $49
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: REXULTI, NUCALA.
Industry payments across CT — which companies pay providers there.
